FDA chides Eli Lilly for 2nd misleading ad in 2 months, this time for diabetes blockbuster Trulicity
After neatly wrapping up concerns over a series of Emgality ads last month, Eli Lilly is back in hot water with the FDA's Office of Prescription Drug Promotion. The FDA gave Lilly a slap on the wrist ...
Florida diabetics are struggling to buy prescription drugs to help control their blood sugar now that the medications have gone viral on social media as a weight-loss solution. The demand from dieters ...
KNOXVILLE, Tenn. (WATE) — It’s hard to watch TV these days without seeing an article or ad praising weight-loss wonder drugs. Some of these drugs, like Trulicity, are approved to treat type 2 diabetes ...
Eli Lilly walks diabetes tightrope as Novo Nordisk shortages drive demand for Trulicity and Mounjaro
Eli Lilly is in prime position with its new GIP/GLP-1 launch tirzepatide and its entrenched diabetes blockbuster Trulicity. Chalk it up to a temporary shortage of its chief rival Novo Nordisk’s ...
Dec 16 (Reuters) - The U.S. health regulator has added Eli Lilly and Co's LLY.N Mounjaro to its list of drugs facing shortages, highlighting the company's struggles to meet booming demand for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback